hs-CRP explained

C-reactive protein is produced by the liver in response to inflammation. The "high-sensitivity" version (hs-CRP) detects low-grade chronic elevations associated with cardiovascular disease, distinct from the sky-high CRP seen in acute infections.

hs-CRP (mg/L)Cardiovascular risk category
<1.0Low (optimal)
1.0-3.0Average
>3.0High
>10Acute inflammation, investigate underlying cause

The Ridker JUPITER trial showed hs-CRP independently predicts cardiovascular events even in people with normal cholesterol (Ridker et al., NEJM 2008).

Homocysteine explained

Homocysteine is an amino acid produced during methionine metabolism. Adequate B-vitamins (B6, B12, folate) keep it low; deficiency causes accumulation. Elevated homocysteine damages endothelium and promotes clotting.

Homocysteine (µmol/L)Risk category
<8Optimal
8-10Acceptable
10-15Elevated, investigate
>15High, increased CV and cognitive risk

Predictive power

Both markers predict events better than cholesterol in many studies. The Framingham analyses show:

Common causes of elevation

Reduction protocol

  1. Lose visceral fat, single biggest lever
  2. Resistance training + zone 2 cardio, both reduce hs-CRP
  3. Omega-3s 2-3 g EPA/DHA daily, directly anti-inflammatory
  4. B-complex with active forms, methylated folate (5-MTHF), methyl-B12, P-5-P (B6) for homocysteine
  5. Diet: high in vegetables, fish, olive oil; low in processed foods
  6. Sleep 7+ hours
  7. Address gum disease, periodontal inflammation contributes meaningfully to systemic CRP
  8. Address chronic infections if suspected
  9. Optimize hormones if low

The principle: Inflammation markers are downstream of multiple system inputs. Single-intervention approaches fail; stack approaches succeed.

Bottom line

hs-CRP and homocysteine are some of the most predictive, and least-ordered, labs in routine medicine. Both rise years before clinical events and respond well to lifestyle and targeted supplementation. Adding them to your standard panel turns invisible early-stage inflammation into a measurable, addressable signal.

<1.0
mg/L, optimal hs-CRP
<8
µmol/L, optimal homocysteine
2x
cardiovascular risk above hs-CRP 3.0